283 related articles for article (PubMed ID: 19282187)
1. Binary and ternary inclusion complexes of finasteride in HPbetaCD and polymers: preparation and characterization.
Asbahr AC; Franco L; Barison A; Silva CW; Ferraz HG; Rodrigues LN
Bioorg Med Chem; 2009 Apr; 17(7):2718-23. PubMed ID: 19282187
[TBL] [Abstract][Full Text] [Related]
2. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
Badr-Eldin SM; Elkheshen SA; Ghorab MM
Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
[TBL] [Abstract][Full Text] [Related]
3. Study of freeze-dried quercetin-cyclodextrin binary systems by DSC, FT-IR, X-ray diffraction and SEM analysis.
Pralhad T; Rajendrakumar K
J Pharm Biomed Anal; 2004 Feb; 34(2):333-9. PubMed ID: 15013147
[TBL] [Abstract][Full Text] [Related]
4. Effect of hydrophilic polymers on isradipine complexation with hydroxypropyl β-cyclodextrin.
Mummidi V; Jayanthi V
Drug Dev Ind Pharm; 2013 Jul; 39(7):970-7. PubMed ID: 22612875
[TBL] [Abstract][Full Text] [Related]
5. Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin.
Figueiras A; Carvalho RA; Ribeiro L; Torres-Labandeira JJ; Veiga FJ
Eur J Pharm Biopharm; 2007 Sep; 67(2):531-9. PubMed ID: 17451924
[TBL] [Abstract][Full Text] [Related]
6. Preparation and characterization of inclusion complexes of prazosin hydrochloride with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
Liu L; Zhu S
J Pharm Biomed Anal; 2006 Jan; 40(1):122-7. PubMed ID: 16095859
[TBL] [Abstract][Full Text] [Related]
7. The influence of polyvinylpyrrolidone on naproxen complexation with hydroxypropyl-beta-cyclodextrin.
Mura P; Faucci MT; Bettinetti GP
Eur J Pharm Sci; 2001 May; 13(2):187-94. PubMed ID: 11297903
[TBL] [Abstract][Full Text] [Related]
8. Artemether/hydroxypropyl-beta-cyclodextrin host-guest system: characterization, phase-solubility and inclusion mode.
Yang B; Lin J; Chen Y; Liu Y
Bioorg Med Chem; 2009 Sep; 17(17):6311-7. PubMed ID: 19665897
[TBL] [Abstract][Full Text] [Related]
9. Effect of beta-cyclodextrin and hydroxypropyl beta-cyclodextrin complexation on physicochemical properties and antimicrobial activity of cefdinir.
Aleem O; Kuchekar B; Pore Y; Late S
J Pharm Biomed Anal; 2008 Jul; 47(3):535-40. PubMed ID: 18367363
[TBL] [Abstract][Full Text] [Related]
10. Improving the solubility of ampelopsin by solid dispersions and inclusion complexes.
Ruan LP; Yu BY; Fu GM; Zhu DN
J Pharm Biomed Anal; 2005 Jul; 38(3):457-64. PubMed ID: 15925247
[TBL] [Abstract][Full Text] [Related]
11. Characterization and molecular modeling of the inclusion complexes of 2-(2-nitrovinyl) furan (G-0) with cyclodextrines.
Ruz V; Froeyen M; Busson R; González MM; Baudemprez L; Van den Mooter G
Int J Pharm; 2012 Dec; 439(1-2):275-85. PubMed ID: 22989977
[TBL] [Abstract][Full Text] [Related]
12. The novel application of tertiary butyl alcohol in the preparation of hydrophobic drug-HPbetaCD complex.
Wang Z; Deng Y; Zhang X
J Pharm Pharmacol; 2006 Mar; 58(3):409-14. PubMed ID: 16536910
[TBL] [Abstract][Full Text] [Related]
13. Hydroxypropyl methylcellulose microspheres with piroxicam and piroxicam-hydroxypropyl-beta-cyclodextrin inclusion complex.
Jug M; Bećirević-Laćan M; Cetina-Cizmek B; Horvat M
Pharmazie; 2004 Sep; 59(9):686-91. PubMed ID: 15497750
[TBL] [Abstract][Full Text] [Related]
14. Effect of PVP K30 and/or L-arginine on stability constant of etoricoxib-HPbetaCD inclusion complex: preparation and characterization of etoricoxib-HPbetaCD binary system.
Shah M; Karekar P; Sancheti P; Vyas V; Pore Y
Drug Dev Ind Pharm; 2009 Jan; 35(1):118-29. PubMed ID: 18979307
[TBL] [Abstract][Full Text] [Related]
15. Cyclodextrin based ternary system of modafinil: Effect of trimethyl chitosan and polyvinylpyrrolidone as complexing agents.
Patel P; Agrawal YK; Sarvaiya J
Int J Biol Macromol; 2016 Mar; 84():182-8. PubMed ID: 26697780
[TBL] [Abstract][Full Text] [Related]
16. Influence of preparation methodology on solid-state properties of an acidic drug-cyclodextrin system.
Govindarajan R; Nagarsenker MS
J Pharm Pharmacol; 2004 Jun; 56(6):725-33. PubMed ID: 15231037
[TBL] [Abstract][Full Text] [Related]
17. Gefitinib-cyclodextrin inclusion complexes: physico-chemical characterization and dissolution studies.
Phillip Lee YH; Sathigari S; Jean Lin YJ; Ravis WR; Chadha G; Parsons DL; Rangari VK; Wright N; Babu RJ
Drug Dev Ind Pharm; 2009 Sep; 35(9):1113-20. PubMed ID: 19640249
[TBL] [Abstract][Full Text] [Related]
18. Dissolution properties and characterization of halofantrine-2-hydroxypropyl-beta-cyclodextrin binary systems.
Onyeji CO; Omoruyi SI; Oladimeji FA
Pharmazie; 2007 Nov; 62(11):858-63. PubMed ID: 18065103
[TBL] [Abstract][Full Text] [Related]
19. Formulation of Apigenin-Cyclodextrin-Chitosan Ternary Complex: Physicochemical Characterization, In Vitro and In Vivo Studies.
Jafar M; Khalid MS; Alghamdi H; Amir M; Al Makki SA; Alotaibi OS; Al Rmais AA; Imam SS; Alshehri S; Gilani SJ
AAPS PharmSciTech; 2022 Feb; 23(2):71. PubMed ID: 35146576
[TBL] [Abstract][Full Text] [Related]
20. Solid-state characterization and dissolution properties of naproxen-arginine-hydroxypropyl-beta-cyclodextrin ternary system.
Mura P; Bettinetti GP; Cirri M; Maestrelli F; Sorrenti M; Catenacci L
Eur J Pharm Biopharm; 2005 Jan; 59(1):99-106. PubMed ID: 15567306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]